# Workit Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/workit-health

- Industry: Healthcare IT
- Headquarters: Ann Arbor, US
- Website: www.workithealth.com
- Total disclosed funding: $93M
- Latest round: Series C (Sep 7, 2021)
- Investors on record: 15

## About

Based in Michigan, US, and founded in 2015 by Lisa McLaughlin, and Robin McIntosh Workit Health, Inc. provides clinically proven telemedicine treatment for substance use disorder, offers online therapy, psychiatric support, medication-assisted treatment, and primary care through the Workit Health mobile app. In October 2021, Workit Health, Inc. raised USD 118 million in a Series C funding led by Insight Partners, with participation from 3L Capital and CVS Health Ventures, BlueCross BlueShield Venture Partners and FirstMark Capital. The Series C funding values Workit Health, Inc. at USD 500 million post-money and has raised a total of USD 137 million in funding. Lisa McLaughlin and Robin McIntosh are the co-CEOs of Workit Health, Inc.

Workit Health, Inc. provides Workit Health mobile application for the treatment of substance use disorder, psychiatric support, medication-assisted treatment, online therapy, and primary care. The company also offers an online addiction care program that provides interactive therapeutic content and professional counseling services. Workit Health provides addiction services such as recovery coaching, online therapy, assessments, and addiction courses. It also offers different kinds of programs like Workit Coach, evaluation and prevention; Workit Counselor, online addiction treatment; and Workit Clinic, for telehealth opioid addiction treatment with medication (like buprenorphine). In addition, the company partners with individuals, health plans, and employers to provide its services. 

Workit Health, Inc. plans to use its proceeds from the Series C funding to accelerate its growth into new markets, as well as expand its primary and psychiatric care offerings, bringing effective care for substance use and co-occurring conditions to people from the privacy of their own homes.

## Funding rounds

- Series C, Sep 7, 2021, $75M — Insight Partners, FirstMark Capital, BlueCross BlueShield Venture Partners, 3L Capital, CVS Health Ventures
- Series B, Oct 30, 2020, $12M — Lux Capital, FirstMark Capital, BlueCross BlueShield Venture Partners, GingerBread Capital
- Series A, Jan 31, 2019, $5M — RRE Ventures, Invest Detroit, Lux Capital, BlueCross BlueShield Venture Partners, Endeavor Catalyst, Montage Ventures, Wakestream Ventures
- Seed, Aug 9, 2016, $1.1M — Lux Capital, Detroit Venture Partners, Start Garden, Montage Ventures, Impact Engine

## Investors

- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed, Series A, Series B
- Detroit Venture Partners (https://capitalatlas.ai/funds/detroit-venture-partners) — Seed
- Start Garden — Seed
- Montage Ventures (https://capitalatlas.ai/funds/montage-ventures) — Seed, Series A
- Impact Engine (https://capitalatlas.ai/funds/impact-engine) — Seed
- RRE Ventures (https://capitalatlas.ai/funds/rre-ventures) — Series A
- Invest Detroit (https://capitalatlas.ai/funds/invest-detroit) — Series A
- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series A, Series B, Series C
- Endeavor Catalyst (https://capitalatlas.ai/funds/endeavor-catalyst) — Series A
- Wakestream Ventures (https://capitalatlas.ai/funds/wakestream-ventures) — Series A
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series B, Series C
- GingerBread Capital (https://capitalatlas.ai/funds/gingerbread-capital) — Series B
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series C
- 3L Capital (https://capitalatlas.ai/funds/3l-capital) — Series C
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series C